AMACR and prostate cancer: Indeed, β-oxidation pathway is suggested to be up-regulated in prostate cancer [32] and α-methylacyl-CoA racemase (AMACR), an enzyme involved in branched chain fatty acid β-oxidation, is already being explored as a diagnostic marker of prostate cancer [33].